This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

CME Group Inc. Names Slate Of Director Nominees And Announces Its Plan To Implement A Majority Vote Standard

CHICAGO, Jan. 31, 2013 /PRNewswire/ -- CME Group today announced its slate of candidates for election to serve on the company's board of directors.  CME Group shareholders will vote for directors at the company's annual meeting to be held Wednesday, May 22, 2013.

The Board also agreed to move forward with the adoption of a majority voting standard and plans to formally adopt amendments to its Bylaws and Corporate Governance Principles prior to its 2013 annual meeting.

"Today's action is the latest in a series of steps we have taken to further strengthen CME Group's corporate governance practices," said Terry Duffy, Executive Chairman & President, CME Group.  "Our move to declassify the Board effective in 2014 and the expiration of our shareholder rights plan demonstrate our commitment to corporate governance."

The Class A and Class B shareholders voting together will elect nine candidates to the board.  Additionally, the Class B-1 and Class B-3 shareholders will each elect a candidate to the board. 

The following candidates will be elected by the Class A and Class B shareholders voting together:
  • Terrence A. Duffy, 54,  Executive Chairman and President, CME Group
  • Charles P. Carey, 59, Former Vice Chairman, CME Group; Partner, Henning and Carey Trading
  • Mark E. Cermak, 61, Director, Execution Services, ABN AMRO Clearing Chicago
  • Martin J. Gepsman, 60, Independent Broker and Trader
  • Leo Melamed, 80, Chairman Emeritus, CME Group; Chairman and Chief Executive Officer, Melamed and Associates, Inc.  
  • Joseph Niciforo, 52, Principal, Henning and Carey Trading
  • C.C. Odom II, 70, Independent Member/Trader; Sole Proprietor, Odom Investments and Argent Venture Capital  
  • Jack F. Sandner, 71, Retired Chairman of the Board, CME Group; Chairman, E*Trade Futures, LLC
  • Dennis H. Suskind, 70, Retired Partner, Goldman Sachs & Co.

One candidate from each of the following Class B-1 and Class B-3 nominees will be elected to the Board.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 17,798.49 -14.90 -0.08%
S&P 500 2,090.11 +1.24 0.06%
NASDAQ 5,127.5250 +11.3820 0.22%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs